Borgstrom F - Search Results

1

European guidance for the diagnosis and management of osteoporosis in postmenopausal women.

Kanis JA, Burlet N, Cooper C, Delmas PD, Reginster JY, Borgstrom F, Rizzoli R; European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). Kanis JA, et al. Among authors: borgstrom f. Osteoporos Int. 2008 Apr;19(4):399-428. doi: 10.1007/s00198-008-0560-z. Epub 2008 Feb 12. Osteoporos Int. 2008. PMID: 18266020 Free PMC article. Review.

2

The risk and burden of vertebral fractures in Sweden.

Kanis JA, Johnell O, Oden A, Borgstrom F, Zethraeus N, De Laet C, Jonsson B. Kanis JA, et al. Among authors: borgstrom f. Osteoporos Int. 2004 Jan;15(1):20-6. doi: 10.1007/s00198-003-1463-7. Epub 2003 Oct 31. Osteoporos Int. 2004. PMID: 14593450

3

Cost-effectiveness of risedronate for the treatment of osteoporosis and prevention of fractures in postmenopausal women.

Kanis JA, Borgstrom F, Johnell O, Jonsson B. Kanis JA, et al. Among authors: borgstrom f. Osteoporos Int. 2004 Nov;15(11):862-71. doi: 10.1007/s00198-004-1643-0. Epub 2004 Jun 3. Osteoporos Int. 2004. PMID: 15175846 Review.

4

Cost-effectiveness of raloxifene in the UK: an economic evaluation based on the MORE study.

Kanis JA, Borgström F, Johnell O, Oden A, Sykes D, Jönsson B. Kanis JA, et al. Among authors: borgstrom f. Osteoporos Int. 2005 Jan;16(1):15-25. doi: 10.1007/s00198-004-1688-0. Epub 2004 Jul 24. Osteoporos Int. 2005. PMID: 15672210 Clinical Trial.

5

At what hip fracture risk is it cost-effective to treat? International intervention thresholds for the treatment of osteoporosis.

Borgström F, Johnell O, Kanis JA, Jönsson B, Rehnberg C. Borgström F, et al. Osteoporos Int. 2006 Oct;17(10):1459-71. doi: 10.1007/s00198-006-0107-0. Epub 2006 Jul 18. Osteoporos Int. 2006. PMID: 16847588

6

Cost-effectiveness of the treatment and prevention of osteoporosis--a review of the literature and a reference model.

Zethraeus N, Borgström F, Ström O, Kanis JA, Jönsson B. Zethraeus N, et al. Among authors: borgstrom f. Osteoporos Int. 2007 Jan;18(1):9-23. doi: 10.1007/s00198-006-0257-0. Epub 2006 Nov 9. Osteoporos Int. 2007. PMID: 17093892 Review.

7

Cost-effectiveness of alendronate in the treatment of postmenopausal women in 9 European countries--an economic evaluation based on the fracture intervention trial.

Ström O, Borgström F, Sen SS, Boonen S, Haentjens P, Johnell O, Kanis JA. Ström O, et al. Among authors: borgstrom f. Osteoporos Int. 2007 Aug;18(8):1047-61. doi: 10.1007/s00198-007-0349-5. Epub 2007 Feb 28. Osteoporos Int. 2007. PMID: 17333449

8

The cost-effectiveness of the treatment of high risk women with osteoporosis, hypertension and hyperlipidaemia in Sweden.

Zethraeus N, Ström O, Borgström F, Kanis JA, Jönsson B. Zethraeus N, et al. Among authors: borgstrom f. Osteoporos Int. 2008 Jun;19(6):819-27. doi: 10.1007/s00198-007-0511-0. Osteoporos Int. 2008. PMID: 18071650

9

Incorporating adherence into health economic modelling of osteoporosis.

Ström O, Borgström F, Kanis JA, Jönsson B. Ström O, et al. Among authors: borgstrom f. Osteoporos Int. 2009 Jan;20(1):23-34. doi: 10.1007/s00198-008-0644-9. Epub 2008 Jun 3. Osteoporos Int. 2009. PMID: 18521650

10

Case finding for the management of osteoporosis with FRAX--assessment and intervention thresholds for the UK.

Kanis JA, McCloskey EV, Johansson H, Strom O, Borgstrom F, Oden A; National Osteoporosis Guideline Group. Kanis JA, et al. Among authors: borgstrom f. Osteoporos Int. 2008 Oct;19(10):1395-408. doi: 10.1007/s00198-008-0712-1. Epub 2008 Aug 28. Osteoporos Int. 2008. PMID: 18751937

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

124 results

Search Page